This Article Full Text (PDF) All Versions of this Article: 1073858406296259v1 13/6/594    most recent References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (1) Citing Articles via Google Scholar Google Scholar Articles by Villmann, C. Articles by Becker, C.-M. Search for Related Content PubMed PubMed Citation Articles by Villmann, C. Articles by Becker, C.-M. Social Bookmarking                   What's this?

On the Hypes and Falls in Neuroprotection: Targeting the NMDA Receptor

Institut für Biochemie, Emil-Fischer-Zentrum Universität Erlangen-Nürnberg

Cord-Michael Becker

Institut für Biochemie, Emil-Fischer-Zentrum Universität Erlangen-Nürnberg, cmb{at}biochem.uni-erlangen.de

Activation of the NMDA (N-methyl-D-aspartate) responsive subclass of glutamate receptors is an important mechanism of excitatory synaptic transmission. Moreover, NMDA receptors are widely involved in many forms of synaptic plasticity such as long-term potentiation (LTP) and long-term depression (LTD), which are thought to underlie complex tasks, including learning and memory. Dysfunction of these ligand-gated cation channels has been identified as an underlying molecular mechanism in neurological disorders ranging from acute stroke to chronic neurodegeneration in amyotrophic lateral sclerosis. Excessive glutamate levels have been detected following brain trauma and cerebral ischemia, resulting in an unregulated stimulation of NMDA receptors. These conditions are thought to elicit a cascade of excitation-mediated neuronal damage where massive increases in intracellular calcium concentrations finally trigger neuronal damage and apoptosis. Consistent with the hypothesis of NMDA receptors as essential mediators of excitotoxicity, the different functional domains of these ion channels have been identified as potential targets for neuroprotective agents. Following an initial hype on potential NMDA receptor therapeutics, the authors currently see a period of skepticism that, in reverse, appears to neglect the therapeutic potential of this receptor class. This review attempts a reappraisal of this important class of neurotransmitter receptors, with a focus on NMDA receptor heterogeneity, ligand binding domains, and candidate diseases for a potential neuroprotective therapy. NEUROSCIENTIST 13(6):594—615, 2007. DOI: 10.1177/1073858406296259

Key Words: NMDA receptors • Excitotoxicity • Synaptic plasticity • Neuroprotection • Drug targets • CNS disorders • Neurodegeneration

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A. D. Steele All quiet on the neuronal front: NMDA receptor inhibition by prion protein J. Cell Biol., May 1, 2008; 181(3): 407 - 409. [Abstract] [Full Text] [PDF]